Nasdaq1mon
Arrivo BioVentures Announces Positive Results from qEEG and BNA™ Study of SP-624 on Neural Brain Activity Related to Depression and Cognition
Assessments, including quantitative EEG (qEEG) and Firefly Neuroscience ... targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners ...
Business Wire1mon
Arrivo BioVentures Announces Positive Results from qEEG and BNA™ Study of SP-624 on Neural Brain Activity Related to Depression and Cognition
Assessments, including quantitative EEG (qEEG) and Firefly Neuroscience ... healthier lives. Arrivo has two clinical-stage pipeline candidates, SP-624 for major depressive disorder and RABI ...